PRO-ENEMA SINGLE SALINE LAXATIVE- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

pro-enema single saline laxative- sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form enema

propharma medical supplies - sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic 7 g in 118 ml - relieves occasional constipation

PADCEV 20 MG Izraelis - anglų - Ministry of Health

padcev 20 mg

astellas pharma international b.v., israel - enfortumab vedotin - powder for concentrate for solution for infusion - enfortumab vedotin 20 mg/vial - enfortumab vedotin - padcev is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (muc) who: - have previously received a programmed death receptor-1 (pd-1) or programmed death-ligand 1 (pd-l1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting or:- are ineligible for cisplatin-containing chemotherapy and have previously received a pd-1/pd-l1 inhibitor.

PADCEV 30 MG Izraelis - anglų - Ministry of Health

padcev 30 mg

astellas pharma international b.v., israel - enfortumab vedotin - powder for concentrate for solution for infusion - enfortumab vedotin 30 mg/vial - enfortumab vedotin - padcev is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (muc) who: - have previously received a programmed death receptor-1 (pd-1) or programmed death-ligand 1 (pd-l1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting or:- are ineligible for cisplatin-containing chemotherapy and have previously received a pd-1/pd-l1 inhibitor.

Padcev Europos Sąjunga - anglų - EMA (European Medicines Agency)

padcev

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastic agents - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Nivolumab BMS Europos Sąjunga - anglų - EMA (European Medicines Agency)

nivolumab bms

bristol-myers squibb pharma eeig - nivolumab - carcinoma, non-small-cell lung - antineoplastic and immunomodulating agents, monoclonal antibodies - nivolumab bms is indicated for the treatment of locally advanced or metastatic squamous non-small cell lung cancer (nsclc) after prior chemotherapy in adults.

SYMFIT - Hearing aid, programmable Australija - anglų - Department of Health (Therapeutic Goods Administration)

symfit - hearing aid, programmable

med-el implant systems australasia pty ltd - 17666 - hearing aid, programmable - the amade audio processor is programmed with connexx software, equipped with the symfit database. this system allows the best fitting for the needs of each individual. the symfit fitting software provides 8 compression channels to optimally fit the patients hearing loss. the 16 band equaliser allows perfect adjustment of the gain in the respective channel. the symfit software is intended to enable the programming of the external parts of the vibrant soundbridge? system and the bonebridge? system.

ViaCath 20/XL/2-8-2 mm - Electrophysiology cardiac catheter, single-use Australija - anglų - Department of Health (Therapeutic Goods Administration)

viacath 20/xl/2-8-2 mm - electrophysiology cardiac catheter, single-use

biotronik australia pty ltd - 46355 - electrophysiology cardiac catheter, single-use - viacath is a steerable catheter for sensing of intracardiac signals & endocardial stimulation. used with a programmed stimulator & an electrophysiological measuring system they are suited for functional diagnostics of the cardiac conduction system. the pt-ir electrodes guarantee smallest possible transition resistances & excellent electrical properties for the intracardiac signals as well as for the stimulation pulses. the cath combines optimal placement accuracy, stiffness & flexibility. the viacath catheters are a temporary, multipolar catheter for sensing of intracardiac signals and diagnostic pacing. it is intended for use in combination with electrophysiology investigation and recording devices during an electrophysiology study (eps) or catheter ablation procedure